California is set to start selling low-cost insulin pens this January, the first such move by a state to circumvent the ...
The state-branded, life-saving drugs for some 3.5 million Californians with diabetes will be much cheaper, the governor ...
Biomea Fusion's experimental drug showed sustained blood sugar control in patients with type 2 diabetes and may benefit those not responding to GLP-1 therapies like Novo Nordisk's Ozempic, it said on ...
In the early 1950s, British physician Philip Hugh-Jones was flummoxed by 13 patients who showed up at the diabetes clinic he ran near Kingston, Jamaica. At the time, researchers broadly recognized two ...
If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 diabetes. Novo Nordisk has resubmitted its biologics license application (BLA ...
SAN DIEGO – Diabetes stakeholders will meet with CMS in October to urge the agency to update its National Coverage Determination (NCD) guidance on who qualifies for an insulin pump to better reflect ...
Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explained how these therapies work to help manage feline diabetes, in ...
UCSF Health transplant specialists recently performed an innovative, minimally invasive pancreatic islet transplant designed to enable a patient with Type 1 diabetes to become insulin independent. The ...
The disease-modifying pill could, used early enough, allow people with type 1 diabetes to be significantly less dependent on insulin treatment.
A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...
We report a 52-year-old man with autoantibody-negative type 1 diabetes (T1D) who presented with severe insulin resistance (IR). Whole-exome sequencing (WES) identified a heterozygous mutation in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results